Clinical trial
Effect of Darbepoetin Alfa (Aranesp®) on Anemia in Patients With Advanced…
NCT00381836 · University of Aarhus, Other · Terminated
Key facts
| NCT number | NCT00381836 |
|---|---|
| Title | Effect of Darbepoetin Alfa (Aranesp®) on Anemia in Patients With Advanced Hormone Independent Prostate Cancer |
| Official title | A Randomized, Multi-center Study to Assess the Effect of Darbepoetin Alfa (Aranesp®) for the Treatment of Anemia in Patients With Advanced Hormone Independent Prostate Cancer and Anaemia |
| Lead sponsor | University of Aarhus, Other |
| Collaborators | Amgen Industry |
| Status | Terminated |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Prostatic Neoplasms, Anemia |
| Intervention type | Drug |
| Interventions | Darbepoetin Alfa |
| Enrollment | 140 |
| Start date | Oct 1, 2006 |
| Primary completion | Feb 1, 2007 |
| Completion | Feb 1, 2007 |
| First posted | Sep 28, 2006 |
| Last update posted | Dec 4, 2015 |
| Countries | Denmark |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: